News | Inspection Team from Nigeria's National Agency for Food and Drug Administration and Control Conducts Factory Audit at Our Company

From September 25 to 26, 2025, an inspection team from Nigeria's National Agency for Food and Drug Administration and Control (NAFDAC) conducted a two-day factory audit at our company. Responsible personnel from relevant departments of the company accompanied the inspection team throughout the process, laying a solid foundation for our export products to enter the Nigerian market。

During the opening meeting of the factory audit, Liu Zhengchao, Chairman and General Manager of the company, along with department heads, held a cordial discussion with the NAFDAC inspection team.The company presented its promotional video and provided a brief introduction to its products and quality assurance system.

Over the two-day audit, the inspection team conducted a comprehensive review of the company's management documents, qualifications, and production records. They performed detailed on-site inspections of the warehouse material system, production equipment and processes, compressed air system, water purification system, instrument laboratory, and testing laboratory. Responsible personnel from Guizhou Tiandi Pharmaceutical's various departments actively cooperated, effectively communicating and addressing issues identified during the inspection, and promptly implementing corrective measures.

Since its establishment 30 years ago, Guizhou Tiandi Pharmaceutical has earned an excellent reputation nationwide through its high-quality products and services. Its domestic sales market primarily covers 18 provinces (regions), including Guizhou, Yunnan, Guangxi, and Guangdong, while its export and contract manufacturing products reach parts of South America, Africa, and Asia. In recent years, the company has maintained annual sales revenue of over 300 million yuan and paid annual taxes exceeding 15 million yuan.

Since 2020, Guizhou Tiandi Pharmaceutical's annual export value for international trade products has been steadily increasing. In 2024, the company obtained international pharmaceutical production quality certification from Ethiopia, the Philippines, and Yemen. It has registered nearly 50 products in more than ten countries, including Nigeria, Peru, and Uzbekistan, laying a solid foundation for entering the international market.

Moving forward, Guizhou Tiandi Pharmaceutical will continue to fully prepare for Good Manufacturing Practice (GMP) certifications and factory audits conducted by foreign drug regulatory authorities, ensuring successful compliance and further expanding legitimate channels for its products into the international market. The company aims to become a leading domestic producer of essential medicines and a major global production base for injectable exports, thereby making greater contributions to local economic and social development.